{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T18:46:57Z","timestamp":1782326817762,"version":"3.54.5"},"reference-count":41,"publisher":"Academy of Managed Care Pharmacy","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.18553\/jmcp.2026.32.7.856","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:52:53Z","timestamp":1782323573000},"page":"856-863","source":"Crossref","is-referenced-by-count":0,"title":["Real-world switching and switch-back patterns among patients transitioning from adalimumab to biosimilars in the United States (February 2023 to August 2025)"],"prefix":"10.18553","volume":"32","author":[{"given":"Karen","family":"Gilbert Farrar","sequence":"first","affiliation":[{"name":"Truveta Inc, Bellevue, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina B.","family":"Masters","sequence":"additional","affiliation":[{"name":"Truveta Inc, Bellevue, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duy","family":"Do","sequence":"additional","affiliation":[{"name":"Truveta Inc, Bellevue, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Stucky","sequence":"additional","affiliation":[{"name":"Truveta Inc, Bellevue, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna M.","family":"Goodwin Cartwright","sequence":"additional","affiliation":[{"name":"Truveta Inc, Bellevue, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7818","reference":[{"key":"r1","volume-title":"StatPearls","author":"Ellis CR","year":"2025"},{"key":"r2","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2019.1637434"},{"key":"r3","doi-asserted-by":"publisher","DOI":"10.1177\/03946320140270S103"},{"key":"r4","unstructured":"Becker Z  . CVS Caremark to kick AbbVie\u2019s Humira off some formularies in favor of cheaper biosimilars. Fierce Pharma. 2024. Accessed August 25, 2025. https:\/\/www.fiercepharma.com\/pharma\/cvs-caremark-kick-abbvies-humira-some-formularies-favor-cheaper-biosimilars."},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026190"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v10.i18.6091"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1592\/phco.30.4.339"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1002\/9783527682423.ch45"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2023.89315"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.23398"},{"key":"r11","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxad120"},{"key":"r12","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2017.23.12.1234"},{"key":"r13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638444"},{"key":"r14","doi-asserted-by":"publisher","DOI":"10.1177\/20406223231223286"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.15872"},{"key":"r16","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00259-8"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-025-00719-z"},{"key":"r18","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae454"},{"key":"r19","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-025-01956-6"},{"key":"r20","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-025-00693-9"},{"key":"r21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-219951"},{"key":"r22","author":"Rodriguez PJ","journal-title":"Pharmacoepidemiol Drug Saf. 2024;33:157-8"},{"key":"r23","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-019-00190-7"},{"key":"r24","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2418-4"},{"key":"r25","first-page":"1","volume":"15","author":"Fitzgerald T","year":"2021","journal-title":"Biologics"},{"key":"r26","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2023.29.1.90"},{"key":"r27","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.02.12"},{"key":"r28","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02173-7"},{"key":"r29","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1652183"},{"key":"r30","unstructured":"Independence Provider News Center . Effective January 1, 2025, IBX is removing Humira\n                      \u00ae\n                      (adalimumab) from its Value, Select, and Premium formularies and switching to a biosimilar. Independence Blue Cross. November 12, 2024. Accessed May 29, 2025. https:\/\/provcomm.ibx.com\/pnc-ibc\/news\/Pages\/Effective-January-1-2025-IBX-is-removing-Humira-adalimumab-from-its-Value-Select-and-Premium-formularies.aspx."},{"key":"r31","unstructured":"Myshko D  . Optum Rx switches up Humira biosimilar coverage for 2025. Managed Healthcare Executive. December 9, 2024. Accessed May 29, 2025. https:\/\/www.managedhealthcareexecutive.com\/view\/optum-rx-switches-up-humira-biosimilar-coverage-for-2025"},{"key":"r32","unstructured":"Provider alert: Simlandi will be our preferred adalimumab product, starting Jan . 1. Blue Cross Blue Shield Blue Care Network of Michigan. October 30, 2024. Accessed May 29, 2025. https:\/\/providerinfo.bcbsm.com\/documents\/alerts\/2024\/202410\/alert-20241030-simlandi-pref-adalimumab-jan-1.pdf"},{"key":"r33","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-019-00169-4"},{"key":"r34","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04576-7"},{"key":"r35","doi-asserted-by":"publisher","DOI":"10.1186\/1476-072X-11-48"},{"key":"r36","doi-asserted-by":"publisher","DOI":"10.14309\/00000434-201710001-00750"},{"key":"r37","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw138"},{"issue":"2","key":"r38","first-page":"65","volume":"12","author":"Rosembert DC","year":"2024","journal-title":"Pharmacy (Basel)"},{"key":"r39","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2025.31.6.552"},{"key":"r40","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-021-00501-x"},{"key":"r41","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01472-1"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T17:54:52Z","timestamp":1782323692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2026.32.7.856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.18553\/jmcp.2026.32.7.856"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2026.32.7.856","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}